biotechnology products
biotechnology products
Unlock Success: Partner with CDMOs for Cell Therapy Manufacturing
📅 May 29, 2024: 🧪 Small biotech companies should engage a CDMO early for cell therapy GMP manufacturing. 📝 Documentation, quality control, and trust are key.
Game-Changing VHH Proteins: Threatening Monoclonal Antibodies?
🔍 VHH proteins could challenge monoclonal antibodies. 💡 They are smaller, simpler, and cheaper, offering advantages in certain applications. 💰💊💪🌍
Revolutionary Technologies Combat Soaring Healthcare Costs
Can new technologies tackle the escalating cost of healthcare? 📅 May 20, 2024: QTL technology and complex systems science offer potential solutions. 👩⚕️👨⚕️
Europe’s Cluster Conference: Boosting Green Digital and Biotech Leadership
💥 More than 900 experts from clusters and the EU Commission gathered in Brussels for the European Cluster Conference. 🌍💪🏼
Revolutionary Biomethane Reactor Sold to Danish CCU Specialist
📅 Electrochaea GmbH has sold a BioCat bioreactor to Danish CCU specialist Again AS. 👥 Again AS uses CO2-fixing archaea to manufacture carbon-negative chemicals at an industrial scale. 💰 Electrochaea sold the bioreactor to Again AS, enriching its R&D work. ♻️ Electrochaea sets a new industry standard for resource efficiency and adaptive bioreactor technology. ⚡️ Electrochaea's biotechnology produces CO2-neutral synthetic methane as a fossil-free alternative for LNG.
Discover the Surprising Dual Nature of One Bacterium
🔍 Researchers discover a bacterium with dual nature: harmful in hospitals, but with potential in dyeing fabrics and medicine. 🧫💉🌈
Unlocking the Power of Industrial IoT in Bioprocessing
📰 The Industrial Internet of Things (IIoT) is revolutionizing bioprocessing, offering better control and streamlined regulatory submissions. 💪💰
Revolutionary Proteins Transform Nutrient Monitoring in Biopharma
🔍 Researchers have developed a potential alternative technology for nutrient monitoring in biopharma using periplasmic binding proteins. 💡
AstraZeneca Acquires Amolyt Pharma for $105bn!
📢 AstraZeneca to acquire Amolyt Pharma for $1.05bn 💼💰 with $800m upfront and potential milestone payments of $250m. Amazing news for biotech in France and Europe!
Revolutionizing Biomolecular Studies with Innovative Technologies
🔍 Re-Imagining Surface Plasmon Resonance for Characterizing Biomolecular Interactions explores innovative technologies to enhance lab accessibility. 🧪💻
